Provided by Tiger Trade Technology Pte. Ltd.

Warrior Met Coal LLC

86.09
-4.5500-5.02%
Post-market: 84.09-2.0000-2.32%19:52 EST
Volume:1.21M
Turnover:105.25M
Market Cap:4.53B
PE:128.68
High:91.43
Open:91.43
Low:85.54
Close:90.64
52wk High:105.35
52wk Low:38.00
Shares:52.57M
Float Shares:51.47M
Volume Ratio:1.01
T/O Rate:2.36%
Dividend:0.32
Dividend Rate:0.37%
EPS(TTM):0.6690
EPS(LYR):4.79
ROE:1.67%
ROA:0.18%
PB:2.14
PE(LYR):17.96

Loading ...

Earnings Flash (HCC) Warrior Met Coal Posts Q4 EPS $0.44, vs. FactSet Est of $0.50

MT Newswires Live
·
8 hours ago

Warrior Met Coal: Q4 EPS $0.44

THOMSON REUTERS
·
8 hours ago

Warrior Met Coal: in 2026, Co Anticipates Challenging Pricing Environment Given Weak Demand, Record High Chinese Steel Exports, Ample Global Supply

THOMSON REUTERS
·
8 hours ago

Warrior Met Coal sees FY26 coal sales 12.5-13.5M short tons

TIPRANKS
·
8 hours ago

Warrior Met Coal Q4 net income rises to USD 23.0 million, up over 20 times

Reuters
·
9 hours ago

Warrior Met Coal: While Volumes Are Expected to Be Higher, Co Anticipates Continued Challenging Pricing Environment Given Weak Demand

THOMSON REUTERS
·
9 hours ago

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
11 hours ago

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical

Reuters
·
Yesterday

Does Warrior Met Coal’s Dividend and Blue Creek Push Reframe Its Capital Allocation Story (HCC)?

Simply Wall St.
·
Yesterday

Coal stocks gain as Trump looks set to issue executive order calling for industry deals with military

Dow Jones
·
Feb 11

Abbisko Advances FGFR4 Inhibitor Irpagratinib With First U.S. Patient Dosed in Global HCC Trial

TIPRANKS
·
Feb 11

Warrior Met Coal Keeps Quarterly Dividend at $0.08 per Share, Payable March 2 to Holders of Record Feb. 23

MT Newswires Live
·
Feb 11

Warrior Met Coal Declares $0.08 Quarterly Dividend

Reuters
·
Feb 11

ABBISKO-B's FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation for Liver Cancer Treatment

Stock News
·
Feb 10

Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy

GlobeNewswire
·
Feb 09

3 Stocks Estimated To Be Undervalued By Up To 25.8% Offering Intriguing Prospects

Simply Wall St.
·
Feb 09

BREAKINGVIEWS-Rio-Glencore fail sets high bar for miner mega-M&A

Reuters
·
Feb 06

Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson

GlobeNewswire
·
Feb 05

Earning Preview: Warrior Met Coal LLC Q4 revenue is expected to increase by 23.62%, and institutional views are broadly constructive

Earnings Agent
·
Feb 05

B. Riley Adjusts Price Target on Warrior Met Coal to $117 From $100, Maintains Buy Rating

MT Newswires Live
·
Feb 04